Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (25)

2023

  1. Effect of a dietary intervention based on the Mediterranean diet on the quality of life of patients recovered from depression: Analysis of the PREDIDEP randomized trial

    Experimental Gerontology, Vol. 175

  2. ‘Effectiveness of a remote nutritional intervention to increase the adherence to the Mediterranean diet among recovered depression patients’

    Nutritional Neuroscience, Vol. 26, Núm. 8, pp. 696-705

2022

  1. Schizophrenia and Hospital Admissions for Cardiovascular Events in a Large Population: The APNA Study

    Journal of Cardiovascular Development and Disease, Vol. 9, Núm. 1

  2. The Modulation of Glutamatergic Signaling as a Potential Therapeutic Strategy for Major Depression

    Glutamate and Neuropsychiatric Disorders: Current and Emerging Treatments (Springer International Publishing), pp. 337-357

2021

  1. Being born in winter–spring and at around the time of an influenza pandemic are risk factors for the development of schizophrenia: The apna study in navarre, spain

    Journal of Clinical Medicine, Vol. 10, Núm. 13

2019

  1. Preventing the recurrence of depression with a Mediterranean diet supplemented with extra-virgin olive oil. the PREDI-DEP trial: Study protocol

    BMC Psychiatry, Vol. 19, Núm. 1

2018

  1. Aberrant timing and oddball detection in Schizophrenia: findings from a signed differential mapping meta-analysis

    Heliyon, Vol. 4, Núm. 12

  2. Diet quality and depression risk: A systematic review and dose-response meta-analysis of prospective studies

    Journal of Affective Disorders, Vol. 226, pp. 346-354

2017

  1. Meta-analysis of functional magnetic resonance imaging studies of timing and cognitive control in schizophrenia and bipolar disorder: Evidence of a primary time deficit

    Schizophrenia Research, Vol. 188, pp. 21-32

  2. Tratamiento de la depresión

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 12, Núm. 46, pp. 2731-2742

2016

  1. Geniuses of medical science: Friendly, open and responsible, not mad

    Medical Hypotheses, Vol. 97, pp. 71-73

  2. Tratamiento del insomnio

    Medicine (Spain), Vol. 12, Núm. 23, pp. 1359-1368

2015

  1. Influencia del polimorfismo Val158Met COMT en el procesamiento de contexto en pacientes del espectro de la esquizofrenia y en sus familiares

    Schizophrenia Research: Cognition, Vol. 2, Núm. 4, pp. 204-209

2014

  1. A schizophrenia-like psychotic disorder secondary to an arachnoid cyst remitted with neurosurgical treatment of the cyst

    The Open Neuroimaging Journal, Vol. 8, Núm. 1, pp. 1-4

2012

  1. Differential expression of prostaglandin D2 synthase (PTGDS) in patients with attention deficit-hyperactivity disorder and bipolar disorder

    Journal of Affective Disorders, Vol. 138, Núm. 3, pp. 479-484

2011

  1. Longitudinal changes in brain structure following the first episode of psychosis

    Psychiatry Research - Neuroimaging, Vol. 191, Núm. 3, pp. 166-173

  2. Multicenter study of brain volume abnormalities in children and adolescent-onset psychosis

    Schizophrenia Bulletin, Vol. 37, Núm. 6, pp. 1270-1280

  3. Psicosis

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 10, Núm. 84, pp. 5693-5702

2007

  1. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: Influence on the severity of psychotic symptoms and on the response to neuroleptic treatment

    Pharmacogenomics Journal, Vol. 7, Núm. 6, pp. 418-426

  2. Perseverative error in schizophrenia: Correlation with cortical blood flow by SPECT

    Actas Espanolas de Psiquiatria, Vol. 35, Núm. 1, pp. 20-28